• Category: Products
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop
Products

FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop

First and only combination drop of carbachol and brimonidine tartrate achieves miosis within 30 minutes and lasts up to 10 hours following once-daily dosing.
FDA approves Glaukos' iDose TR for repeat treatment labeling
Products

FDA approves Glaukos' iDose TR for repeat treatment labeling

Travoprost intracameral implant can now be re-administered using a repeat treatment protocol—enabling greater flexibility in glaucoma patient management.
FDA approves Alembic's difluprednate 0.05% generic
Products

FDA approves Alembic's difluprednate 0.05% generic

Generic version of Sandoz’s Durezol is indicated for postop pain and inflammation as well as endogenous anterior uveitis.
Nidek launches Phantom Open-field Refraction System
Products

Nidek launches Phantom Open-field Refraction System

Device corrects refractive errors with virtual lenses simulating the same properties as real lenses—in under 5 minutes.
OCuSOFT launches Retaine Omega Forte for dry eye
Products

OCuSOFT launches Retaine Omega Forte for dry eye

New nutritional supplement offers a daily dose of omega-3 essential fatty acids.
Focus Vitamins launches PF artificial tears for dry eye
Products

Focus Vitamins launches PF artificial tears for dry eye

Manufactured by cGMP- and NSF-certified suppliers, Focus Tears PF Eye Drops are formulated with CMC sodium 0.5% to offer temporary ocular relief.
WAVE Lens Designer Software integrates with Topcon MYAH
Products

WAVE Lens Designer Software integrates with Topcon MYAH

Integration enables direct import of corneal topography data into custom lens platform, streamlining the specialty contact lens design workflow.
Dr. Reddy's olopatadine HCl 0.7% launches as first-to-market generic
Products

Dr. Reddy's olopatadine HCl 0.7% launches as first-to-market generic

The OTC eye drop is a bioequivalent to Alcon’s Once Daily Extra Strength, with ocular allergy relief lasting 24 hours.
FDA clears Rayner's Sophi phacemulsification system
Products

FDA clears Rayner's Sophi phacemulsification system

First battery-powered, wireless phaco system features triple pump fluidics for more control of anterior chamber stability during cataract surgery.
FDA approves Gland Pharma's OTC Extra Strength Pataday generic
Products

FDA approves Gland Pharma's OTC Extra Strength Pataday generic

Olopatadine HCl ophthalmic solution 0.7% is indicated to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander for 24 hours.
Euclid Vision launches new SiHy daily disposable lens for myopia
Products

Euclid Vision launches new SiHy daily disposable lens for myopia

The Be Free Day soft lens for pediatric myopes features BHVI's proprietary dual action, multistep optical design technology.
FDA clears first EDOF contact lens for presbyopia
Products

FDA clears first EDOF contact lens for presbyopia

U.S. approval is first for a daily disposable, extended-depth-of-field lens requiring no patient cognitive adaptation period for presbyopia correction.
FDA approves Formycon and Bioeq's Lucentis biosimilar
Products

FDA approves Formycon and Bioeq's Lucentis biosimilar

Nufymco (ranibizumab-leyk) marks the companies’ second ranibizumab biosimilar cleared in the U.S. to treat five retinal indications.
Your rundown: 2025 approvals and launches
Products

Your rundown: 2025 approvals and launches

Take a trip down memory lane for a look at this year’s latest additions to the ophthalmic space.
Rinsada expands irrigating eyelid retractor distribution to Canada
Products

Rinsada expands irrigating eyelid retractor distribution to Canada

Already FDA-cleared in the U.S., the medical device is now registered by Health Canada and only available through online retailer Eye Drop Shop.
FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension
Products

FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension

Generic of Bausch + Lomb’s ZYLET for steroid-responsive inflammatory ocular conditions qualifies for 6 months of market exclusivity once commercially launched.
Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief
Products

Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief

Clinical experts share OD-MD insights into the advanced artificial tears’ hydrating PF formulation with active glycerin and hyaluronic acid. 
Amneal receives FDA approval for Restasis generic
Products

Amneal receives FDA approval for Restasis generic

Generic version of Allergan’s cyclosporine ophthalmic emulsion 0.05% eye drop for dry eye is the second to receive U.S. regulatory clearance.
Evoq launches FDA-registered dark adaptation testing device for IRDs
Products

Evoq launches FDA-registered dark adaptation testing device for IRDs

The Twilight is a wearable and smartphone-based diagnostic tool for at-home, remote monitoring of retinal health and early retinal disease detection.
FDA approves new EYLEA HD indication, expanded dosing intervals
Products

FDA approves new EYLEA HD indication, expanded dosing intervals

Intravitreally-administered 2 mg aflibercept therapeutic is now cleared for macular edema following retinal vein occlusion.